We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Harmony Biosciences
HRMY
$2.26B
| $0 | ﹤0.01% |
+8
| New | +$258 |
2021 Q3
0 quarters
|
|
3127
Hydrofarm Holdings
HYFM
$3.86M
| – | – |
-2
| Closed | -$1K | – |
|
3128
Hyliion Holdings
HYLN
$570M
| $0 | ﹤0.01% |
34
+10
| +42% | +$92 |
2020 Q3
4 quarters
|
|
3129
CALL
People Inc
PPLI
$3B
| – | – |
-853
| Closed | -$176K | – |
|
3130
Installed Building Products
IBP
$5.01B
| – | – |
-150
| Closed | -$18K | – |
|
3131
DELISTED
iCAD Inc
ICAD
| – | – |
-55
| Closed | -$1K | – |
|
3132
iShares Convertible Bond ETF
ICVT
$7.64B
| – | – |
-50
| Closed | -$5K | – |
|
3133
InterDigital
IDCC
$8.34B
| $0 | ﹤0.01% |
4
| – | – |
2019 Q4
7 quarters
|
|
3134
DELISTED
IGM Biosciences
IGMS
| $0 | ﹤0.01% |
+4
| New | +$306 |
2021 Q3
0 quarters
|
|
3135
Brightstar Lottery PLC
BRSL
$1.78B
| – | – |
-2
| Closed | – | – |
|
3136
NovaBridge Biosciences American Depositary Shares
NBP
$149M
| $0 | ﹤0.01% |
6
-7
| -54% | -$506 |
2021 Q2
1 quarter
|
|
3137
iShares Morningstar Mid-Cap ETF
IMCB
$1.7B
| – | – |
-76
| Closed | -$5K | – |
|
3138
Immunic
IMUX
$94.3M
| – | – |
0
| – | – |
2018 Q2
13 quarters
|
|
3139
Immunovant
IMVT
$5.8B
| – | – |
-14,262
| Closed | -$151K | – |
|
3140
indie Semiconductor
INDI
$457M
| $0 | ﹤0.01% |
+10
| New | +$98 |
2021 Q3
0 quarters
|
|
3141
inTEST
INTT
$160M
| – | – |
-325
| Closed | -$5K | – |
|
3142
Interparfums
IPAR
$3.75B
| $0 | ﹤0.01% |
+5
| New | +$366 |
2021 Q3
0 quarters
|
|
3143
DELISTED
iRobot
IRBT
| – | – |
-24
| Closed | -$2K | – |
|
3144
Ironwood Pharmaceuticals
IRWD
$626M
| $0 | ﹤0.01% |
+22
| New | +$284 |
2021 Q3
0 quarters
|
|
3145
Jack in the Box
JACK
$242M
| $0 | ﹤0.01% |
+3
| New | +$313 |
2021 Q3
0 quarters
|
|
3146
St. Joe Company
JOE
$3.87B
| – | – |
-162
| Closed | -$7K | – |
|
3147
JPMorgan Diversified Return International Equity ETF
JPIN
$383M
| – | – |
-2,198
| Closed | -$137K | – |
|
3148
KALA BIO
KALA
$3.82M
| – | – |
0
| – | – |
2021 Q1
2 quarters
|
|
3149
DELISTED
KalVista Pharmaceuticals
KALV
| $0 | ﹤0.01% |
8
-37
| -82% | -$750 |
2021 Q2
1 quarter
|
|
3150
KKR Real Estate Finance Trust
KREF
$356M
| $0 | ﹤0.01% |
+18
| New | +$382 |
2021 Q3
0 quarters
|
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.